Core Viewpoint - The company reported a revenue of approximately 1.094 billion yuan for the first half of the year, marking a year-on-year growth of 4.40%, while the net profit attributable to shareholders reached about 118 million yuan, reflecting a significant increase of 45.76% [1] Group 1: Financial Performance - The company's asset-liability ratio stood at 49.47% at the end of the reporting period, a decrease of 0.08 percentage points compared to the end of 2024 [1] - The company achieved export sales of 260 million yuan, which is a year-on-year increase of 50.71% [1] Group 2: Business Model and Focus Areas - The company is one of the earliest institutions in China focusing on hard technology investment, leveraging a unique business model that integrates technology innovation services with strategic emerging industries [1] - Strategic emerging industries, particularly new materials, are a major source of revenue for the company [1] Group 3: Investment and Innovation - The company completed 11 investment delivery projects in the first half of the year, with investment returns significantly increasing compared to the same period last year [1] - The company has a total of 248 ongoing investment projects, with the following sector allocations based on investment amount: 16.06% in new generation information technology, 47.35% in advanced manufacturing, 15.44% in new energy materials, and 7.98% in biomedical [1] Group 4: Technology Transfer and Project Development - The company has successfully transformed technology achievements from universities such as Beijing Institute of Technology and Harbin Institute of Technology (Shenzhen) into early-stage quality projects [2] - Investments were made in companies like Zhongke Fifth Epoch, Habitat Technology, and Lepulan, covering areas such as intelligent technology-driven design and manufacturing [2] - Several invested companies have submitted listing applications to the Hong Kong Stock Exchange, and others have completed new rounds of financing [2]